Clene Provides Update On Its NIH-Funded Expanded Access Program For CNM-Au8® In ALS (ACT-EAP)
Stay updated with breaking news from Russo Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
02.05.2024 - SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) - Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that it will report ...
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 LONDON, April 25, 2024 /PRNewswire/ --...
NervGen Pharma Corp. , a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that it has engaged Russo Partners LLC , a...
22.04.2024 - The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ETCORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage ...